AstraZeneca, Ionis close deal on antisense therapy development

AstraZeneca, Ionis close deal on antisense therapy development

Submitted by admin on December 30, 2021 - 11:07am
Source: 
Pharmaceutical Business Review
News Tags: 
AstraZeneca
Ionis Pharmaceuticals
antisense
eplontersen
Headline: 
AstraZeneca, Ionis close deal on antisense therapy development
snippet: 

AstraZeneca and Ionis Pharmaceuticals have closed a previously announced commercialisation agreement to develop and market experimental therapy, eplontersen, previously called IONIS-TTR-LRX.

Do Not Allow Advertisers to Use My Personal information